Clinical Trials Directory

Trials / Completed

CompletedNCT04963114

Art Therapy Program in the Chronic Phase of Stroke

Art Therapy Program in the Chronic Phase of Stroke: A Feasibility Pilot Study

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
7 (actual)
Sponsor
Université de Sherbrooke · Academic / Other
Sex
All
Age
65 Years – 79 Years
Healthy volunteers
Not accepted

Summary

INTRODUCTION: After stroke, perceptual impairments, such as negative body perception, contribute to social isolation and depression. In the subacute poststroke phase, art therapy is effective in improving depression, self-esteem, and community integration. Yet, no study has explored the effectiveness of art therapy at the chronic stage of a stroke; where motor recovery is slowed, and body image and self-esteem are deeply challenged. OBJECTIVES: Primary; to assess the feasibility of an art therapy program (ATP) in the chronic phase of stroke. Secondary; to explore the effects of ATP on perceptual impairment (body image/self-esteem), mood and community integration. METHOD: Nine adults (stroke ≥6 months) will participate in the ATP consisting of a thematic group visit to the Montreal Museum of Fine Arts followed by an art workshop, supervised by an art therapist (7 visits over 4 months). Feasibility will be evaluated by triangulating data from interviews and subject assessment questionnaires and by assessing retention and attendance. The effects of the ATP will be assessed by changes in perceptual and mood impairment questionnaires (Body Image States, Self-Esteem scales, Beck Depression Inventory-Short-Form) and community integration questionnaire (The Community Integration Questionnaire). EXPECTED RESULTS AND OUTCOMES: The project will confirm the feasibility of ATP to improve perceptual impairment and community integration post-stroke.

Conditions

Interventions

TypeNameDescription
BEHAVIORALart therapyguided art tour and workshop

Timeline

Start date
2018-08-09
Primary completion
2019-12-06
Completion
2019-12-06
First posted
2021-07-15
Last updated
2021-07-15

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT04963114. Inclusion in this directory is not an endorsement.